Netskope, Inc., a cybersecurity company, provides security, networking, and analytics solutions to largest enterprises to mid-sized companies worldwide.
FAIL · Does not pass the screen
14.70 USD
At the last full screen 2026-09-11
Screened 2026-09-11 · the tape above runs as of 23:00 UTC · 17 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markup label.
Netskope, Inc. holds its Markup at $14.70. Consolidating, no directional conviction, held for 34 days.
As held on the ledger · 2026-09-11
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 34 days
Price at the screen
$14.70
Valuation
N/A trailing · 532.22 forward price to earnings
Values screen
FAIL· score 70.0
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
42.61%
Below 33%
Interest-bearing debt is 42.6% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
40.94%
Below 33%
Interest-bearing cash and securities are 40.9% of assets, above the one-third limit.
Fail
Receivables
33.34%
Below 49%
Money owed to the company is 33.3% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. The price runs 35.5% above the base estimate.
Third-party analyst targets: 18 covering, consensus Strong Buy. The average target sits +24% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Cloud Security Name Priced Well Beyond Reality
Picture a mid-sized firm moving its entire workforce online. Every click and file transfer now needs protection that older tools cannot provide. Netskope sells exactly that service through its cloud platform and revenue is rising 28 percent a year. Yet the shares sit at 955 times forward earnings while the company loses 95 cents on every dollar of sales. Our fair value sits 42 percent below the current price, so the opportunity rating is none.
The market appears to be betting that rapid adoption will soon turn those losses into fat profits. Analyst targets cluster around 16 dollars, well above where we see fair value. Growth alone does not justify such a multiple when margins remain deeply negative and the moat is still unproven.
High expectations leave little room for the usual delays that hit software roll-outs. Currency moves or a slower shift to cloud tools could widen losses further. The ethical screen is clear, yet the numbers still point to material downside from here. Analysis, not advice.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
NTSK trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-02Markup$13.50+0.0%Entry 12
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-01Markup$13.50+0.0%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-31Markup$13.50+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-30Markup$13.50+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-29Markup$13.50+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-28Markup · changed$13.50+0.0%Entry 7
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-27Accumulation$13.50+0.0%Entry 6
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-07Markup · changed$13.59+50.3%Entry 4
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 50.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18.
2026-07-18Accumulation$9.04+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.